Validation and implementation of the Australian Treatment Outcomes Profile in specialist drug and alcohol settings-Reference-Cited by-同舟云学术

Validation and implementation of the Australian Treatment Outcomes Profile in specialist drug and alcohol settings

Published:2013-11-11 Issue:1 Volume:33 Page:33-42
ISSN:0959-5236
Container-title:Drug and Alcohol Review
language:en
Short-container-title:Drug Alcohol Rev

Author:

Ryan Anni¹,Holmes Jennifer¹,Hunt Vi²,Dunlop Adrian²,Mammen Kristie¹,Holland Rohan²,Sutton Yvonne³,Sindhusake Doungkamol⁴,Rivas Gonzalo¹,Lintzeris Nicholas¹

Affiliation:

1. South Eastern Sydney Local Health District Drug and Alcohol Service; Sydney Australia

2. Hunter New England Local Health District Drug and Alcohol Clinical Services; Newcastle Australia

3. Sydney South West Area Drug Health Service; Sydney Australia

4. University of Western Sydney; Sydney Australia

Funder

Mental Health Drug and Alcohol Office of New South Wales Health

Publisher

Wiley

Subject

Health(social science),Medicine (miscellaneous)

Reference35 articles.

1. Drug treatment series;Australian Institute of Health and Welfare,2011

2. The New South Wales health outcomes program;Fromme;N S W Public Health Bull,1992

3. Optimizing clinical care through implementation of outcome monitoring systems;Lawrinson;Drug-Educ Prev Polic,2009

4. Defining and classifying clinical indicators for quality improvement;Mainz;Int J Qual Health Care,2003

5. Teesson M Clement N Copeland J Conroy A Reid A The measurement of outcome in alcohol and other drug treatment: a review of available instruments 2000

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Implementation of time-limited parenteral hydromorphone in people with treatment-resistant injecting opioid use disorder: a protocol for a single-site, uncontrolled, open-label study to assess feasibility, safety and cost;BMJ Open;2024-08

2. Sociodemographic and Health Factors of the Alcohol Treatment-seeking Population in New South Wales, Australia;Journal of Addiction Medicine;2024-06-03

3. Validity of the brief executive-function assessment tool in an outpatient substance use disorder setting;Applied Neuropsychology: Adult;2024-05-09

4. 96-week retention in treatment with extended-release subcutaneous buprenorphine depot injections among people with opioid dependence: Extended follow-up after a single-arm trial;International Journal of Drug Policy;2024-05

5. The dual orexin receptor antagonist suvorexant in alcohol use disorder and comorbid insomnia: A case report;Clinical Case Reports;2024-05